Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista de la Asociación Española de Neuropsiquiatría
versión On-line ISSN 2340-2733versión impresa ISSN 0211-5735
Resumen
SESMA PARDO, Eva; FINKLE, Joshua; GONZALEZ TORRES, Miguel Ángel y GAVIRIA, Moisés. Perimenopausal depression: a review. Rev. Asoc. Esp. Neuropsiq. [online]. 2013, vol.33, n.120, pp.681-691. ISSN 2340-2733. https://dx.doi.org/10.4321/S0211-57352013000400002.
From adolescence, women have a 1.5 to 3 times higher risk than men of suffering from a depressive disorder. This risk increases in the transition period to menopause or perimenopause, when the depressive vulnerability becomes especially intense. Hormonal, psychological and sociocultural factors have been suggested to understand the etiopathogeny of these disorders. Treatment of depression in perimenopause is determined by clinical severity and includes antidepressants, psychotherapy, and sometimes, hormone replacement therapy with estrogens. Perimenopausal depression is an underdiagnosed and poorly treated problem, which generates a high level of suffering and deserves greater attention by clinicians and health systems.
Palabras clave : Depression; Perimenopause; Estrogens.